Resource Library

Data Sheet: GORE Protein Capture Device for Early Clinical Applications, 9.0mL (PROA103)

Data Sheets, United States

The 9.0mL Device (PROA103) GORE Protein Capture Device provides performance advantages over traditional agarose resin columns in late stage discovery, pre-clinical and early clinical applications.

View as PDF (242.9 KB)

Contact Us

Americas

+1 800 294 4673

+1 410 506 1715

Europe

+49 89 4612 3456

+800 4612 3456

All Other Inquiries

+1 800 294 4673

+1 410 506 1715

Contact by email

Related Products

Pharmaceutical & Biopharmaceutical

Affinity chromatography devices

Chromatography News & Events

Event

Visit GORE at BioProcessing Summit in Boston

August 15, 2022 - August 18, 2022

Press Release

Gore PharmBIO Introduces 116mL and 232mL Protein Capture Devices with Protein A to Increase Productivity and Throughput for Antibody Purification

Posted April 5, 2022

W.L. Gore & Associates, Inc. continues to build on its growing portfolio of protein capture devices with the introduction of its new 116mL and 232mL GORE® Protein Capture Devices with Protein A. The offerings strengthen Gore’s chromatography device portfolio and follow the commercial availability of its 58mL Protein Capture Device in Q4 of 2021.

Event

Visit GORE at World ADC Europe 2022

March 29, 2022 - April 1, 2022

Visit GORE in-person or virtually at this year’s World ADC Europe. Gore is participating as an exhibition partner to showcase expertise in providing leading pharmaceutical companies with an innovative, Protein A membrane chromatography device to improve productivity in affinity purification of monoclonal antibodies. Discuss how a membrane column could be the missing single use purification link.